Chundsell Medicals (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Business model:
B2B
Investors:
we tracked 1 investor
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Chundsell Medicals AB was founded in 2007 as a spin off from Cancer Center Karolinska (Karolinska Institutet, Stockholm, Sweden) in order to transfer the research results of Dr. Chunde Li and his group into clinical reality.

Companies with similar profile to Chundsell Medicals:

CompanyCriteria
Finland Blueprint Genetics
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Creathor Venture
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Scandinavian Real Hearts
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Elypta
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland TILT Biotherapeutics
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland Sooma Medical
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland BitBar
34%
  • Similar business models: B2B
  • At least one vc investor: Creathor Venture
  • Minim one investor from outside Scandinavia: Yes
Iceland Key Natura
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Norway OncoImmunity
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Denmark Oncology Venture
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Norway Cytovation
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Omnio AB
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Denmark Antag Therapeutics
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden BoneSupport
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Merozyne Therapeutics
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Athera
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland Mobidiag
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Ilya Pharma
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Monocl
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B